http://www-1.ibm.com/support/docview.wss?rs=663&tc=SSGSG7&uid=swg21197133 ??

-H.
 

-----Original Message-----
From: ADSM: Dist Stor Manager [mailto:ADSM-L AT VM.MARIST DOT EDU] On Behalf Of 
Howard Coles
Sent: den 14 mars 2008 15:54
To: ADSM-L AT VM.MARIST DOT EDU
Subject: Re: [ADSM-L] Support w2k

>From what I have read in the Client readmes and other places the last client 
>to support W2K Server was 5.4.x.  I haven't seen any notices until the 5.5 
>client that W2K was not supported.

See Ya'
Howard

> -----Original Message-----
> From: ADSM: Dist Stor Manager [mailto:ADSM-L AT VM.MARIST DOT EDU] On Behalf 
> Of Christoph Pilgram
> Sent: Friday, March 14, 2008 9:26 AM
> To: ADSM-L AT VM.MARIST DOT EDU
> Subject: [ADSM-L] Support w2k
> 
> Hi all,
> 
> Does anybody know which tsm-client is supported to run on w2k-server 
> (last supported version I found was 5.3 that goes now out of support)
> 
> Mit freundlichen Grüßen / Kind regards Christoph Pilgram
> 
> Boehringer Ingelheim Pharma GmbH & Co. KG A Informationsverarbeitung
> Tel.: +49 (7351) 54-4051
> Fax: +49 (7351) 54-2157
> mailto:christoph.pilgram AT boehringer-ingelheim DOT com
> 
> Boehringer Ingelheim Pharma GmbH & Co. KG, Sitz: Ingelheim am Rhein; 
> Registergericht Mainz: HR A 22206; Komplementär Boehringer Ingelheim 
> Deutschland GmbH; Geschäftsführung: Ulrich Pitkamin (Vorsitzender), 
> Axel Eppert (stellv. Vorsitzender), Dr. Wolfgang Baiker, Hubertus von 
> Baumbach, Dr. Uwe Bücheler, Dr. Norbert Camp, Mark Hagmann, Dr. André 
> Hertkorn, Dr.
> Michel Pairet, Dr. Herbert Stein, Dr. Martin Wanning; Vorsitzender des
> Aufsichtsrates: Dr. Dr. Andreas Barner; Sitz: Ingelheim am Rhein; 
> Registergericht Mainz: HR B 23260
> 
> Diese E-Mail ist vertraulich zu behandeln. Sie kann besonderem 
> rechtlichen Schutz unterliegen. Wenn Sie nicht der richtige Adressat 
> sind, senden Sie bitte diese E-Mail an den Absender zurück, löschen 
> die eingegangene E- Mail und geben den Inhalt der E-Mail nicht weiter. 
> Jegliche unbefugte Bearbeitung, Nutzung, Vervielfältigung oder 
> Verbreitung ist verboten. / This e-mail is confidential and may also 
> be legally privileged. If you are not the intended recipient please 
> reply to sender, delete the e-mail and do not disclose its contents to 
> any person. Any unauthorized review, use, disclosure, copying or 
> distribution is strictly prohibited.


-------------------------------------------------------------------
The information contained in this message may be CONFIDENTIAL and is
intended for the addressee only. Any unauthorised use, dissemination of the
information or copying of this message is prohibited. If you are not the
addressee, please notify the sender immediately by return e-mail and delete
this message.
Thank you.